Nephros, Inc. (NEPH) Tops Q3 EPS by 5c

Nephros, Inc. (NASDAQ: NEPH) reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.74 million versus the consensus estimate of $3.31 million.

For earnings history and earnings-related data on Nephros, Inc. (NEPH) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• SCYNEXIS (SCYX) PT Raised to $33 at Guggenheim
• SBC Medical Group Holdings Incorporated (SBC) Misses Q2 EPS by 2c